Literature DB >> 31241403

When to Consider Bisphosphonates in Patients on Steroids for Chronic Ocular Inflammatory Conditions.

Jaskirat S Takhar1,2, Varun K Pawar1,3, Athanasios G Marneris1,3, Thuy A Doan1,3, Nisha R Acharya1,3, John A Gonzales1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31241403      PMCID： PMC7141554          DOI： 10.1089/jop.2019.0058

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN： 1080-7683            Impact factor:   2.671


× No keyword cloud information.
  4 in total

Review 1.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

Review 2.  2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Authors:  Lenore Buckley; Gordon Guyatt; Howard A Fink; Michael Cannon; Jennifer Grossman; Karen E Hansen; Mary Beth Humphrey; Nancy E Lane; Marina Magrey; Marc Miller; Lake Morrison; Madhumathi Rao; Angela Byun Robinson; Sumona Saha; Susan Wolver; Raveendhara R Bannuru; Elizaveta Vaysbrot; Mikala Osani; Marat Turgunbaev; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Rheumatol       Date:  2017-06-06       Impact factor: 10.995

3.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

Review 4.  Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Authors:  Ethel S Siris; Sanford Baim; Aurelia Nattiv
Journal:  Postgrad Med       Date:  2010-01       Impact factor: 3.840
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.